• Consumer Stories
  • People-first Pharmacy Care

A Mission to Provide a Higher Level of Care

Jan 21st, 2021

“Crossing paths with Arielle happened by chance,” said Genoa Healthcare site manager, Michael L. of Waterbury, Connecticut.

It was another bustling day in Michael’s pharmacy when he picked up the ringing phone. A new consumer, Arielle D., was on the other end of the line. She was exhausted and frustrated.

Genoa pharmacist Michael Lewis, left, and technician David Torres, right

After weeks of filling out paperwork and making calls to get her prescription approved and filled with her previous pharmacy, she was still without her medication.

“I don’t ever give up and this was the first time that I felt like giving up,” Arielle said. “I’m not sure if I would be here today if I was never transferred to Michael.”

Becoming a pharmacist was more of calling than a choice for Michael. After his mother was diagnosed with cancer, he was impressed by the high level of care that his mother’s pharmacy team provided her during treatment. This personal experience led him to change his area of study from engineering to pharmacy.

Driven by his mission to deliver compassionate, high-quality care, he leapt into action for Arielle. With her permission, he started making calls to root out the issue that was causing the delay, and persisted until the error was corrected. Arielle got her medication that same day.

“It truly serves as testament to Mike’s passion for providing care. He’s one of our star pharmacists and this instance goes to show why,” said Simar Singh, director of operations.

“This is what Genoa stands for. This is who we are,” said Michael, explaining why he went above and beyond for Arielle. “I would have done the same thing for anyone.”

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...